ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats
Journal of Veterinary Internal Medicine · 2024
DOI: 10.1111/jvim.17079 ↗At a glance
Journal article in Journal of Veterinary Internal Medicine, 2024. Written by Dana N LeVine and 24 co-authors. Institution: Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, Alabama, USA. Major MEDLINE topics: Cat Diseases, Dog Diseases, Purpura, Thrombocytopenic, Idiopathic. Cited 25 times so far (Crossref); 181 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Management of immune thrombocytopenia (ITP) in dogs and cats is evolving, but there are no evidence-based guidelines to assist clinicians with treatment decisions. Likewise, the overall goals for treatment of ITP have not been established. Immunosuppressive doses of glucocorticoids are the first line treatment, but optimal treatment regimens beyond glucocorticoids remain uncertain. Additional options include secondary immunosuppressive drugs such as azathioprine, modified cyclosporine, and mycophenolate mofetil, usually selected based on clinician preference. Vincristine, human IV immunoglobulin (hIVIg), and transfusion of platelet or red blood cell–containing products are often used in more severe cases. Splenectomy and thrombopoietin receptor agonists are usually reserved for refractory cases, but when and in which patient these modalities should be employed is under debate. To develop evidence-based guidelines for individualized treatment of ITP patients, we asked 20 Population Intervention Comparison Outcome (PICO) format questions. These were addressed by 17 evidence evaluators using a literature pool of 288 articles identified by a structured search strategy. Evidence evaluators, using panel-designed templates and data extraction tools, summarized evidence and created guideline recommendations. These were integrated by treatment domain chairs and then refined by iterative Delphi survey review to reach consensus on the final guidelines. In addition, 19 non-PICO questions covering scenarios in which evidence was lacking or of low quality were answered by expert opinion using iterative Delphi surveys with panelist integration and refinement. Commentary was solicited from multiple relevant professional organizations before finalizing the consensus. The rigorous consensus process identified few comparative treatment studies, highlighting many areas of ITP treatment requiring additional studies. This statement is a companion manuscript to the ACVIM Consensus Statement on the Diagnosis of Immune Thrombocytopenia in Dogs and Cats.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, Alabama, USA.
- Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
- Small Animal Clinic, School of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
- Department of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, USA.
- Linda Kidd Veterinary Internal Medicine Consulting, Carlsbad, California, USA.
- School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana, USA.
ORCID profiles: Dana N LeVine, Robert Goggs, Andrew J Mackin, Linda Kidd, Oliver A Garden, Marjory B Brooks, Anthony Abrams-Ogg, Elizabeth H Appleman, Todd M Archer, Shauna L Blois, Benjamin M Brainard, Mary Beth Callan, Claire L Fellman, Jillian M Haines, John M Lucy, Shana K O'Marra, Elizabeth A Rozanski, John M Thomason, Helen E Wilson
Cite
APA
LeVine, D. N., Goggs, R., Kohn, B., Mackin, A. J., Kidd, L., Garden, O. A., Brooks, M. B., Eldermire, E. R. B., Abrams-Ogg, A., Appleman, E. H., Archer, T. M., Bianco, D., Blois, S. L., Brainard, B. M., Callan, M. B., Fellman, C. L., Haines, J. M., Hale, A. S., Huang, A. A., …, & Wilson, H. E. (2024). ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17079
Vancouver
LeVine DN, Goggs R, Kohn B, Mackin AJ, Kidd L, Garden OA, et al. ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17079
BibTeX
@article{LeVine2024,
author = {LeVine, Dana N and Goggs, Robert and Kohn, Barbara and Mackin, Andrew J and Kidd, Linda and Garden, Oliver A and Brooks, Marjory B and Eldermire, Erin R B and Abrams-Ogg, Anthony and Appleman, Elizabeth H and Archer, Todd M and Bianco, Domenico and Blois, Shauna L and Brainard, Benjamin M and Callan, Mary Beth and Fellman, Claire L and Haines, Jillian M and Hale, Anne S and Huang, Alice A and Lucy, John M and O'Marra, Shana K and Rozanski, Elizabeth A and Thomason, John M and Walton, Jenny E and Wilson, Helen E},
title = {ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats},
journal = {Journal of Veterinary Internal Medicine},
year = {2024},
doi = {10.1111/jvim.17079}
}
EUVIMED